# Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia

> **NCT00872326** · PHASE1,PHASE2 · COMPLETED · sponsor: **Andalusian Network for Design and Translation of Advanced Therapies** · enrollment: 20 (actual)

## Conditions studied

- Peripheral Vascular Diseases
- Diabetic Foot

## Interventions

- **PROCEDURE:** Autologous Bone Marrow Mononuclear Cells

## Key facts

- **NCT ID:** NCT00872326
- **Lead sponsor:** Andalusian Network for Design and Translation of Advanced Therapies
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2014-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00872326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00872326, "Autologous Bone Marrow Derived Mononuclear Cells in Treating Diabetic Patients With Critical Limb Ischemia". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00872326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*